These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9818023)

  • 21. Aberrant FHIT transcripts in Merkel cell carcinoma.
    Sozzi G; Alder H; Tornielli S; Corletto V; Baffa R; Veronese ML; Negrini M; Pilotti S; Pierotti MA; Huebner K; Croce CM
    Cancer Res; 1996 Jun; 56(11):2472-4. PubMed ID: 8653678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FHIT gene abnormalities in both benign and malignant thyroid tumours.
    Zou M; Shi Y; Farid NR; al-Sedairy ST; Paterson MC
    Eur J Cancer; 1999 Mar; 35(3):467-72. PubMed ID: 10448301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of FHIT transcripts in cervical and endometrial cancers.
    Su TH; Wang JC; Tseng HH; Chang CP; Chang TA; Wei HJ; Chang JG
    Int J Cancer; 1998 Apr; 76(2):216-22. PubMed ID: 9537583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract.
    Chen YJ; Chen PH; Lee MD; Chang JG
    Int J Cancer; 1997 Sep; 72(6):955-8. PubMed ID: 9378557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Tsujiuchi T; Sasaki Y; Murata N; Tsutsumi M; Konishi Y; Nakae D
    Carcinogenesis; 2001 Dec; 22(12):2017-22. PubMed ID: 11751434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
    Zoubek A; Dockhorn-Dworniczak B; Delattre O; Christiansen H; Niggli F; Gatterer-Menz I; Smith TL; Jürgens H; Gadner H; Kovar H
    J Clin Oncol; 1996 Apr; 14(4):1245-51. PubMed ID: 8648380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased or altered expression of the FHIT gene in human leukemias.
    Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
    Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [FHIT gene is abnormal in Chinese lung cancers].
    Zhang J; Fu W; Zhang X
    Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):592-5. PubMed ID: 11715406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
    Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
    Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
    J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable FHIT transcripts in non-neoplastic tissues.
    Panagopoulos I; Thelin S; Mertens F; Mitelman F; Aman P
    Genes Chromosomes Cancer; 1997 Aug; 19(4):215-9. PubMed ID: 9258655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel EWSR1-CREB3L1 fusion transcript in a case of small cell osteosarcoma.
    Debelenko LV; McGregor LM; Shivakumar BR; Dorfman HD; Raimondi SC
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1054-62. PubMed ID: 21987447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
    Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
    Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
    Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sequence analyses of aberrant FHIT transcripts in gastric cancer cell lines].
    Lee SH; Kim HS
    Korean J Gastroenterol; 2003 Dec; 42(6):476-83. PubMed ID: 14695704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
    Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
    Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant FHIT transcripts in hepatocellular carcinomas.
    Chen YJ; Chen PH; Chang JG
    Br J Cancer; 1998; 77(3):417-20. PubMed ID: 9472637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.